The harmful misconception that antidepressants are ‘no better than placebo’ is a popular one, making the rounds year after year.  Equivocations like this are not only false but a gross misrepresentation of the evidence.  A new meta-analysis published in the Lancet will hopefully take this falsehood behind the barn and put it down for good. […]

Read More →

Alzheimer’s disease is a notoriously difficult condition to diagnose, often only being confirmed at autopsy. The disease affects millions of people, but current tests such as PET scans and CSF samples are expensive, time-consuming, and invasive. A paradigm-shifting test for Alzheimer’s has been developed by a joint Japanese-Australian team which screens for specific biomarkers in […]

Read More →

This paper examines the ever-increasing use of electronic cigarettes as a possible alternative to the use of combustible tobacco products. The authors note that many anti-tobacco advocacy groups tend to focus on the adverse effects of electronic cigarette use, rather than noting the potential benefits of these nicotine delivery systems. The authors argue that electronic […]

Read More →